OCAM
HEPA

Onex Canada Asset Management’s Hepion Pharmaceuticals HEPA Stock Holding History

Onex Canada Asset Management’s Portfolio HEPA Stock Details HEPA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-40
Closed -$74K – 173
2021
Q1 		$74K Buy
40
+20
+100% +$43.8K ﹤0.01% 197
2020
Q4 		$44K Buy
+20
New +$51.8K ﹤0.01% 132

Other funds holding HEPA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Onex Canada Asset Management's HEPA Position: Q2 2021 in Review

Onex Canada Asset Management sold out of Hepion Pharmaceuticals (HEPA) in Q2 2021, closing a stake of 40 shares — an estimated $74K sold.

Onex Canada Asset Management first reported a position in HEPA in Q4 2020 and held it in 2 quarters. The position peaked at $74K in Q1 2021. 43 funds tracked by Wall St. Rank hold HEPA as of Q2 2021.

  • Onex Canada Asset Management reported no remaining Hepion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Onex Canada Asset Management sold 40 Hepion Pharmaceuticals shares in Q2 2021, an estimated $74K.
  • Onex Canada Asset Management first reported a position in Hepion Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • Onex Canada Asset Management's Hepion Pharmaceuticals position peaked at $74K in Q1 2021.
  • 43 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q2 2021.

Based on Onex Canada Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.